BioSpace News Archive

Gain Therapeutics, Inc. announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present at the 12th Annual Jefferies London Healthcare Conference and invites investors to participate in one-on-one meetings both in-person on Tuesday and Wednesday November 16th/17th or virtually on Thursday and Friday November 18th/19th.

Exagen Inc., a leading provider of autoimmune testing solutions, announced its participation in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum, which takes place November 18th, 2021.

Aeterna Zentaris Inc., a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, reported its financial and operating results for the third quarter ended September 30, 2021.

NextCure, Inc.NextCure, Inc.NextCure, Inc.NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, reported third quarter 2021 financial results and provided a business update.

T2 Biosystems, Inc.T2 Biosystems, Inc.T2 Biosystems, Inc.T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens, announced financial results for the three months ended September 30, 2021.

Zogenix, a global biopharmaceutical company developing rare disease therapies, announced financial results for the three and nine months ended September 30, 2021, and provided a corporate update.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, reported its financial results for the third quarter ended September 30, 2021 and provided a corporate update.

Eiger BioPharmaceuticals, Inc. today reported its third quarter 2021 financial results and provided a business update.

Axonics, Inc. today reported financial results for the third quarter ended September 30, 2021.

Insulet Corporation today announced financial results for the three months ended September 30, 2021.